Sign inGet started

Rosen Howard B

Insider CIK 1307068 · ACRX Intermin CEO, Director · KALA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KALA KALA BIO, Inc. A Award deriv2025-06-152025-06-175,450— $05,450SEC↗
KALA KALA BIO, Inc. A Award2025-06-152025-06-172,450— $016,240SEC↗
KALA KALA BIO, Inc. A Award deriv2024-06-112024-06-123,150— $03,150SEC↗
KALA KALA BIO, Inc. A Award2024-06-112024-06-121,400— $013,887SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award deriv2023-10-102023-12-133,487— $03,487SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award2023-10-102023-12-13581— $05,293SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2023-06-222023-06-2310,651— $010,651SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2023-06-222023-06-232,500— $02,500SEC↗
KALA Kala Pharmaceuticals, Inc. A Award2023-06-222023-06-231,100— $012,487SEC↗
KALA Kala Pharmaceuticals, Inc. A Award2023-06-222023-06-237,988— $011,387SEC↗
KALA Kala Pharmaceuticals, Inc. D To issuer deriv2023-05-312023-06-02764— $00SEC↗
KALA Kala Pharmaceuticals, Inc. D To issuer deriv2023-05-312023-06-02259— $00SEC↗
KALA Kala Pharmaceuticals, Inc. D To issuer deriv2023-05-312023-06-02259— $00SEC↗
KALA Kala Pharmaceuticals, Inc. D To issuer deriv2023-05-312023-06-02420— $00SEC↗
KALA Kala Pharmaceuticals, Inc. D To issuer deriv2023-05-312023-06-02800— $00SEC↗
KALA Kala Pharmaceuticals, Inc. A Award2023-05-312023-06-022,502— $03,399SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award deriv2022-07-152022-07-1531,000— $031,000SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award2022-07-152022-07-1515,500— $094,250SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2022-06-162022-06-1740,000— $040,000SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award deriv2021-06-172021-06-1720,000— $020,000SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award2021-06-172021-06-1710,000— $078,750SEC↗
KALA Kala Pharmaceuticals, Inc. A Award2021-06-172021-06-2120,000— $044,824SEC↗
KALA Kala Pharmaceuticals, Inc. A Award2020-06-252020-06-2920,000— $024,824SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award deriv2020-06-162020-06-1615,000— $015,000SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award2020-06-162020-06-167,500— $068,750SEC↗
KALA Kala Pharmaceuticals, Inc. M Exercise deriv2019-08-192020-06-291,944— $00SEC↗
KALA Kala Pharmaceuticals, Inc. M Exercise deriv2019-08-192020-06-292,880— $00SEC↗
KALA Kala Pharmaceuticals, Inc. M Exercise2019-08-192020-06-292,880$0.68 $2.0K2,880SEC↗
KALA Kala Pharmaceuticals, Inc. M Exercise2019-08-192020-06-291,944$0.47 $9144,824SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award deriv2019-06-252019-06-257,500— $07,500SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award2019-06-252019-06-253,750— $061,250SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2019-06-052019-06-0721,000— $021,000SEC↗
KALA Kala Pharmaceuticals, Inc. P Buy2019-05-302019-06-035,000$5.42 $27.1K8,240SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award deriv2018-06-142018-06-1415,000— $015,000SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2018-06-122018-06-1412,960— $012,960SEC↗
KALA Kala Pharmaceuticals, Inc. A Award deriv2017-07-192017-07-2112,960— $012,960SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award deriv2017-06-152017-06-1515,000— $015,000SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award deriv2017-02-072017-02-17366,000— $0366,000SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy2016-05-132016-05-1610,206$3.26 $33.3K50,000SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award deriv2016-03-282016-03-30800,000— $0800,000SEC↗
ACRX ACELRX PHARMACEUTICALS INC P Buy2015-05-192015-05-2035,400— $039,794SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award deriv2015-04-012015-04-03240,000— $0240,000SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award deriv2014-07-242014-07-2815,000— $015,000SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award deriv2013-09-122013-09-1615,000— $015,000SEC↗
ACRX ACELRX PHARMACEUTICALS INC A Award deriv2012-07-242012-07-2612,500— $012,500SEC↗